The Global neutropenia drugs market is anticipated to grow at a CAGR of 5.0% during the forecast period. The major factors for growth of the market include the increasing prevalence of cancer cases along with increasing investment in R&D by companies, to develop various novel therapies for the treatment of this disease, which will fuel the growth of the market during the forecast period.

Free Sample Copy @ https://www.omrglobal.com/request-sample/neutropenia-drugs-market

Neutropenia is a disease where the number of white blood cells (neutrophils) present in the blood are reduced significantly, further hampering the immune system of the patient. In 2019, 9.8 million new cancer patients received chemotherapy treatment, according to the Lancet Oncology journal. The chemotherapy affects the count of WBCs, as some of them die during the treatment. This aspect will further grow the demand of the market during the forecast period. According to the WHO around more than 15 million patients will go under chemotherapy treatment by 2040.

A Full Report of Global Neutropenia Drugs Market is Available at:
https://www.omrglobal.com/industry-reports/neutropenia-drugs-market

According to the International Agency for Research on Cancer, in 2018, 169,270 people were living with leukemia and 58,876 new leukemia cases were diagnosed in North America. In February 2018, Partner Therapeutics, a Boston-based cancer company, acquired Leukine (Sargramostim) from Sanofi for $60 million, which is used for the treatment of leukemia. Some of the key global players in theneutropenia drugs marketinclude Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, and many others.

Global Neutropenia Drugs Market – Segmentation
By Treatment
Colony-stimulation factor
Antibiotics
Antifungal
Antiviral
By Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Neutropenia Drugs Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Teva Pharmaceutical
Amgen
Sanofi
Mylan
Kyowa Kirin
Baxter International

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neutropenia-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404